Taketomi A - Search Results

1

Natural killer cell activity in patients with hepatocellular carcinoma: a new prognostic indicator after hepatectomy.

Taketomi A, Shimada M, Shirabe K, Kajiyama K, Gion T, Sugimachi K. Taketomi A, et al. Cancer. 1998 Jul 1;83(1):58-63. doi: 10.1002/(sici)1097-0142(19980701)83:1<58::aid-cncr8>3.0.co;2-a. Cancer. 1998. PMID: 9655293

2

Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma. Comparison with alpha-fetoprotein.

Suehiro T, Sugimachi K, Matsumata T, Itasaka H, Taketomi A, Maeda T. Suehiro T, et al. Among authors: taketomi a. Cancer. 1994 May 15;73(10):2464-71. doi: 10.1002/1097-0142(19940515)73:10<2464::aid-cncr2820731004>3.0.co;2-9. Cancer. 1994. PMID: 7513601

3

Thrombomodulin inhibits intrahepatic spread in human hepatocellular carcinoma.

Suehiro T, Shimada M, Matsumata T, Taketomi A, Yamamoto K, Sugimachi K. Suehiro T, et al. Among authors: taketomi a. Hepatology. 1995 May;21(5):1285-90. Hepatology. 1995. PMID: 7537712

4

Des-gamma-carboxy prothrombin and proliferative activity of hepatocellular carcinoma.

Suehiro T, Matsumata T, Itasaka H, Taketomi A, Yamamoto K, Sugimachi K. Suehiro T, et al. Among authors: taketomi a. Surgery. 1995 Jun;117(6):682-91. doi: 10.1016/s0039-6060(95)80013-1. Surgery. 1995. PMID: 7539944

5

A comparison of the surgical results in patients with hepatitis B versus hepatitis C-related hepatocellular carcinoma.

Takenaka K, Yamamoto K, Taketomi A, Itasaka H, Adachi E, Shirabe K, Nishizaki T, Yanaga K, Sugimachi K. Takenaka K, et al. Among authors: taketomi a. Hepatology. 1995 Jul;22(1):20-4. Hepatology. 1995. PMID: 7601413

6

Levels of amino acids in human hepatocellular carcinoma and adjacent liver tissue.

Nishizaki T, Matsumata T, Taketomi A, Yamamoto K, Sugimachi K. Nishizaki T, et al. Among authors: taketomi a. Nutr Cancer. 1995;23(1):85-90. doi: 10.1080/01635589509514364. Nutr Cancer. 1995. PMID: 7739918

7

Outpatient follow-up system using a personal computer for patients with hepatocellular carcinoma after surgery.

Itasaka H, Matsumata T, Taketomi A, Yamamoto K, Yanaga K, Takenaka K, Akazawa K, Sugimachi K. Itasaka H, et al. Among authors: taketomi a. J Med Syst. 1994 Dec;18(6):329-33. doi: 10.1007/BF00999274. J Med Syst. 1994. PMID: 7745368

8

Occurrence of intraperitoneal septic complications after hepatic resections between 1985 and 1990.

Matsumata T, Yanaga K, Shimada M, Shirabe K, Taketomi A, Sugimachi K. Matsumata T, et al. Among authors: taketomi a. Surg Today. 1995;25(1):49-54. doi: 10.1007/BF00309385. Surg Today. 1995. PMID: 7749290

9

A new approach for liver surgery. Transdiaphragmatic hepatectomy for cirrhotic patients with hepatocellular carcinoma.

Shimada M, Matsumata T, Taketomi A, Shirabe K, Yamamoto K, Itasaka H, Sugimachi K. Shimada M, et al. Among authors: taketomi a. Arch Surg. 1995 Feb;130(2):157-60. doi: 10.1001/archsurg.1995.01430020047007. Arch Surg. 1995. PMID: 7848085

10

Initiation of a fibrinolytic system in hepatic resection: the roles of tissue-type plasminogen activator and plasminogen activator inhibitor-1.

Shimada M, Matsumata T, Yamamoto K, Itasaka H, Taketomi A, Sugimachi K. Shimada M, et al. Among authors: taketomi a. Surg Today. 1994;24(9):780-4. doi: 10.1007/BF01636306. Surg Today. 1994. PMID: 7865953 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results